MedPath

COLORADO DENVER UNIVERSITY OF

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

Emergency Department (ED) Drug Interaction in Emergency Department Patients

Not Applicable
Completed
Conditions
Drug Interactions
Interventions
First Posted Date
2013-05-22
Last Posted Date
2016-05-05
Lead Sponsor
University of Colorado, Denver
Target Recruit Count
502
Registration Number
NCT01859715
Locations
🇺🇸

University of Colorado, Aurora, Colorado, United States

Effects of an Antioxidant-Enriched Multivitamin Supplement on Inflammation and Oxidative Stress in Cystic Fibrosis

Phase 2
Completed
Conditions
Cystic Fibrosis
Interventions
Drug: AquADEKs-2
Dietary Supplement: control multivitamin
First Posted Date
2013-05-21
Last Posted Date
2017-07-14
Lead Sponsor
University of Colorado, Denver
Target Recruit Count
73
Registration Number
NCT01859390
Locations
🇺🇸

Children's Hospital of Pittsburgh of UPMC, Pittsburgh, Pennsylvania, United States

🇺🇸

Penn State Milton S. Hershey Medical Center, Hershey, Pennsylvania, United States

🇺🇸

Rainbow Babies and Children's Hospital, Cleveland, Ohio, United States

and more 12 locations

Mineralocorticoid Antagonism and Endothelial Dysfunction in Autosomal Dominant Polycystic Kidney Disease (ADPKD)

Phase 3
Completed
Conditions
ADPKD
Interventions
Drug: Sugar pill
First Posted Date
2013-05-15
Last Posted Date
2019-08-20
Lead Sponsor
University of Colorado, Denver
Target Recruit Count
61
Registration Number
NCT01853553
Locations
🇺🇸

UColorado, Aurora, Colorado, United States

Phase I Study to Evaluate the Safety and Pharmacokinetics of Oral Doses of Anvylic-3288 in Healthy Subjects

Phase 1
Terminated
Conditions
Schizophrenia
Interventions
Device: AVL-3288
Drug: Placebo
First Posted Date
2013-05-10
Last Posted Date
2016-12-30
Lead Sponsor
University of Colorado, Denver
Target Recruit Count
12
Registration Number
NCT01851603
Locations
🇺🇸

U of Colorado Denver, Aurora, Colorado, United States

Effects of Estrogen Deficiency on Energy Expenditure

Not Applicable
Completed
Conditions
Obesity
Interventions
Drug: Estrogen suppression
First Posted Date
2013-05-03
Last Posted Date
2019-11-18
Lead Sponsor
University of Colorado, Denver
Target Recruit Count
6
Registration Number
NCT01846728
Locations
🇺🇸

University of Colorado Anschutz Medical Campus, Aurora, Colorado, United States

Study of Abiraterone Acetate and Prednisone in Combination With Cabazitaxel in Patients With Prostate Cancer

Phase 2
Terminated
Conditions
Prostate Cancer
Interventions
First Posted Date
2013-05-03
Last Posted Date
2018-06-04
Lead Sponsor
University of Colorado, Denver
Target Recruit Count
7
Registration Number
NCT01845792
Locations
🇺🇸

University of Colorado Cancer Center, Aurora, Colorado, United States

PF-04449913 For Patients With Acute Myeloid Leukemia at High Risk of Relapse After Donor Stem Cell Transplant

Phase 2
Completed
Conditions
Recurrent Adult Acute Myeloid Leukemia
Adult Acute Myeloid Leukemia in Remission
Interventions
First Posted Date
2013-04-26
Last Posted Date
2022-01-25
Lead Sponsor
University of Colorado, Denver
Target Recruit Count
31
Registration Number
NCT01841333
Locations
🇺🇸

University of Colorado Cancer Center, Aurora, Colorado, United States

🇺🇸

Ohio State University, Columbus, Ohio, United States

A Trial of Neuroprotection With ACTH in Acute Optic Neuritis

Phase 4
Terminated
Conditions
Multiple Sclerosis
Interventions
First Posted Date
2013-04-23
Last Posted Date
2023-04-27
Lead Sponsor
University of Colorado, Denver
Target Recruit Count
37
Registration Number
NCT01838174
Locations
🇺🇸

University of Colorado Denver, Aurora, Colorado, United States

🇺🇸

University of Pennsylvania Scheie Eye Institute, Philadelphia, Pennsylvania, United States

Compassionate Use of Stiripentol in Dravet Syndrome

Conditions
Dravet Syndrome
First Posted Date
2013-04-18
Last Posted Date
2019-10-04
Lead Sponsor
University of Colorado, Denver
Registration Number
NCT01835314
Locations
🇺🇸

Children's Hospital Colorado, Aurora, Colorado, United States

The Effects of Cannabis Use in People With Schizophrenia on Clinical, Neuropsychological and Physiological Phenotypes

Phase 1
Terminated
Conditions
Schizophrenia
Interventions
Other: Placebo Comparator
First Posted Date
2013-04-16
Last Posted Date
2015-09-21
Lead Sponsor
University of Colorado, Denver
Target Recruit Count
13
Registration Number
NCT01832766
Locations
🇺🇸

University of Colorado Denver, Aurora, Colorado, United States

© Copyright 2025. All Rights Reserved by MedPath